Int J Heart Fail.
2022 Jan;4(1):1-11. 10.36628/ijhf.2021.0024.
Clinical Implication of Genetic Testing in Dilated Cardiomyopathy
- Affiliations
-
- 1Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, National Institute of Health, Cheongju, Korea
- 2Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea
- 3Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 4Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea
- KMID: 2532558
- DOI: http://doi.org/10.36628/ijhf.2021.0024
Abstract
- Dilated cardiomyopathy (DCM) is one of the important causes of heart failure (HF). With the rapidly evolving technologies for gene analysis and tremendous advances in knowledge of HF genetics, the importance of genetic testing in DCM is currently highlighted. Several genetic variants causing DCM have been identified and this information is used for diagnosis, risk stratification and family screening of DCM patients. However, there are still several challenges in applying genetic testing to real clinical practice. In this review, we will summarize recent understandings in DCM genetics and provide an evidence-based practical guide to the use of genetic testing for DCM patients.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics
- Echocardiographic Study of the Aortic Root and Valve in Dilated Cardiomyopathy
- Duchenne Muscular Dystrophy Complicated With Dilated Cardiomyopathy and Cerebral Infarction
- Clinical Study on Dilated Cardiomyopathy in Children
- Vanishing Left Ventricular Thrombi in Severe Aortic Stenosis with Dilated Cardiomyopathy
